搜尋結果
文章
Bai, K. J. ,
Tung, N. T. ,
Hsiao, T. C. ,
Chen, T. L. ,
Chung, K. F. ,
Ho, S. C. ,
Tsai, C. Y. ,
Chen, J. K. ,
Lee, C. N. ,
Lee, K. Y. ,
Chang, C. C. ,
Chen, T. T. ,
Feng, P. H. ,
Chen, K. Y. ,
Su, C. L. ,
Thao, H. N. X. ,
Dung, H. B. ,
Thuy, T. P. C. ,
Lee, Y. L. &
Chuang, H. C. ,
1月 2022 ,
於: Environmental Science and Pollution Research. 29 ,
4 ,
p. 6140-6150 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
tuberculosis
100%
Air Pollution
98%
Pleurisy
97%
Particulate Matter
91%
Pulmonary Tuberculosis
78%
Hsieh, R. L. ,
Huang, Y. L. ,
Chen, W. J. ,
Chen, H. H. ,
Shiue, H. S. ,
Lin, Y. C. &
Hsueh, Y. M. ,
2月 1 2022 ,
於: Nutrients. 14 ,
4 , 911.
研究成果: 雜誌貢獻 › 文章 › 同行評審
bone density
100%
vitamin B12
85%
folic acid
81%
Vitamin B 12
80%
Folic Acid
72%
Lee, K. Y. ,
Chiang, L. L. ,
Ho, S. C. ,
Liu, W. T. ,
Chen, T. T. ,
Feng, P. H. ,
Su, C. L. ,
Chuang, K. J. ,
Chang, C. C. &
Chuang, H. C. ,
7月 11 2016 ,
於: International Journal of COPD. 11 ,
1 ,
p. 1569-1578 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lung Volume Measurements
100%
Air Pollution
87%
air pollution
83%
Autophagy
72%
Chronic Obstructive Pulmonary Disease
67%
Duong, T. V. ,
Wong, T. C. ,
Su, C. T. ,
Chen, H. H. ,
Chen, T. W. ,
Chen, T. H. ,
Hsu, Y. H. ,
Peng, S. J. ,
Kuo, K. L. ,
Liu, H. C. ,
Lin, E. T. &
Yang, S. H. ,
6月 1 2018 ,
於: Medicine (United States). 97 ,
26 , e11306.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Micronutrients
100%
Renal Dialysis
76%
Nutrients
74%
Cardiovascular Diseases
63%
Practice Guidelines
41%
Kao, C. C. ,
Cheng, S. Y. ,
Wu, M. Y. ,
Chien, S. C. ,
Lu, H. F. ,
Hsu, Y. W. ,
Zhang, Y. F. ,
Wu, M. S. &
Chang, W. C. ,
9月 7 2017 ,
於: BMC Nephrology. 18 ,
1 , 291.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Endothelins
100%
Renal Insufficiency
75%
Chronic Kidney Failure
60%
Genes
27%
Tibial Arteries
24%
Lin, J. D. ,
Yang, S. F. ,
Wang, Y. H. ,
Fang, W. F. ,
Lin, Y. C. ,
Liou, B. C. ,
Lin, Y. F. ,
Tang, K. T. &
Cheng, C. W. ,
9月 1 2017 ,
於: PLoS One. 12 ,
9 , e0185529.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Melatonin Receptors
100%
Melatonin
91%
Graves Disease
79%
melatonin
73%
single nucleotide polymorphism
52%
Chen, K-Y. ,
Kuo, H-Y. ,
Lee, K-Y. ,
Feng, P-H. ,
Wu, S-M. ,
Chuang, H-C. ,
Chen, T-T. ,
Sun, W-L. ,
Tseng, C-H. ,
Liu, W-T. ,
Cheng, W-H. ,
Majumdar, A. ,
Stettler, M. ,
Tsai, C-Y. &
Ho, S-C. ,
2023 ,
於: Frontiers in Medicine. 9 研究成果: 雜誌貢獻 › 文章 › 同行評審
Van Duong, T. ,
Wu, P. Y. ,
Yang, E. ,
Lin, Y. F. ,
Chiou, H. Y. &
Yang, S. H. ,
12月 2 2019 ,
於: International journal of environmental research and public health. 16 ,
24 , 5093.
研究成果: 雜誌貢獻 › 文章 › 同行評審
socioeconomic factor
100%
socioeconomic factors
89%
Waist Circumference
84%
environmental factors
77%
Chronic Renal Insufficiency
77%
Chang, C. H. ,
Chen, K. C. ,
Liaw, K. C. ,
Peng, C. C. &
Peng, R. Y. ,
1月 5 2020 ,
於: Molecules. 25 ,
1 , 214.
研究成果: 雜誌貢獻 › 文章 › 同行評審
astaxanthine
100%
Astaxanthin
94%
glutamates
89%
Homocysteine
82%
Neurotoxicity
81%
Lin, Y. F. ,
Sheng, L. H. ,
Wu, M. Y. ,
Zheng, C. M. ,
Chang, T. J. ,
Li, Y. C. ,
Huang, Y. H. &
Lu, H. P. ,
12月 1 2014 ,
於: Journal of the Chinese Medical Association. 77 ,
12 ,
p. 642-647 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Blood Pressure
100%
Physicians
99%
Kidney
84%
Proteinuria
33%
Chronic Renal Insufficiency
32%
Lin, Y. L. ,
Chen, H. H. &
Chen, T-W. ,
2月 2008 ,
於: NDT Plus. 1 ,
1 ,
p. 45-48 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lai, P. F. ,
Cheng, C. F. ,
Lin, H. ,
Tseng, T. L. ,
Chen, H. H. &
Chen, S. H. ,
2013 ,
於: Evidence-based Complementary and Alternative Medicine. 2013 , 716481.
研究成果: 雜誌貢獻 › 文章 › 同行評審
HMGB1 Protein
100%
Lipopolysaccharides
64%
Inflammation
44%
Sepsis
40%
Innate Immunity
23%
Wei, L. ,
Chen, J. S. ,
Lin, H. T. ,
Wu, C. Z. ,
Zheng, C. M. ,
Chang, Y. C. ,
Chang, L. C. &
Lin, Y. F. ,
2月 1 2017 ,
於: Journal of the Chinese Medical Association. 80 ,
2 ,
p. 86-95 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Urokinase Plasminogen Activator Receptors
100%
Atorvastatin
86%
Urokinase-Type Plasminogen Activator
81%
Actins
60%
Endothelial Cells
53%
Chen, J. S. ,
Hwang, J. C. ,
Chang, L. C. ,
Wu, C. C. &
Lin, Y. F. ,
12月 2010 ,
於: Archives of Pathology and Laboratory Medicine. 134 ,
12 ,
p. 1804-1812 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
plasminogen kringle 5
100%
Glomerulonephritis
54%
Membranous Glomerulonephritis
49%
Kringles
38%
Endothelial Cells
23%
Tseng, M. H. ,
Lin, S. H. ,
Tsai, J. D. ,
Wu, M. S. ,
Tsai, I. J. ,
Chen, Y. C. ,
Chang, M. C. ,
Chou, W. C. ,
Chiou, Y. H. &
Huang, C. C. ,
2022 , (接受/付印)
於: Journal of the Formosan Medical Association. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Atypical Hemolytic Uremic Syndrome
100%
Taiwan
65%
Complement Inactivating Agents
19%
Haemolytic Anaemia
15%
Acute Kidney Injury
12%
Percutaneous Coronary Intervention
100%
Myocardial Infarction
72%
Elderly
67%
Comorbidity
19%
Non-ST Elevated Myocardial Infarction
16%
Liu, J. C. ,
Hsu, Y. P. ,
Zhu, J. C. ,
Hao, W. R. ,
Yang, T. Y. ,
Sung, L. C. ,
Kao, P. F. ,
Hwang, J. &
Hsiu, H. ,
2021 ,
於: Clinical Hemorheology and Microcirculation. 79 ,
3 ,
p. 365-379 15 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Pulse
100%
Essential Hypertension
92%
Lasers
70%
Laser-Doppler Flowmetry
66%
Hypertension
57%
Chou, C. L. ,
Pang, C. Y. ,
Lee, T. J. F. &
Fang, T. C. ,
3月 16 2015 ,
於: PLoS ONE. 10 ,
3 , e0119843.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Calcitriol
100%
Fructose
97%
Glucose Intolerance
90%
Adiposity
89%
Vasodilation
82%
Valsartan Drug Combination Amlodipine
100%
adiposity
75%
Lipolysis
67%
Fructose
66%
lipolysis
65%
Chen, K. C. ,
Peng, C. H. ,
Wang, H. E. ,
Peng, C. C. ,
Peng, R. Y. ,
Kaplan, S. A. ,
Wang, W. ,
Bergh, A. ,
Damber, J. E. ,
Benaim, E. A. ,
Karam, J. A. ,
Soboorian, M. H. ,
Roehrborn, C. G. ,
McConnell, J. D. &
Lin, V. ,
4月 2005 ,
於: Journal of Urology. 173 ,
4 ,
p. 1266-1267 2 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chen, K. C. ,
Sung, S. Y. ,
Lin, Y. T. ,
Hsieh, C. L. ,
Shen, K. H. ,
Peng, C. C. &
Peng, R. Y. ,
11月 17 2015 ,
於: BMC Urology. 15 ,
1 , 113.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Prostatic Hyperplasia
100%
Type 1 Diabetes Mellitus
81%
Androgen Receptors
44%
Testosterone
36%
Somatomedins
26%
Wang, M. Y. ,
Chan, S. F. ,
Chang, L-I. ,
Chen, T. H. &
Tsai, P. S. ,
11月 2013 ,
於: International Journal of Nursing Studies. 50 ,
11 ,
p. 1468-1473 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Dialysis
100%
Sleep
91%
Observational Studies
91%
Cross-Sectional Studies
76%
Anxiety
21%
Feng, P-H. ,
Chen, K-Y. ,
Huang, Y-C. ,
Luo, C-S. ,
Wu, S. M. ,
Chen, T-T. ,
Lee, C-N. ,
Yeh, C-T. ,
Chuang, H-C. ,
Han, C-L. ,
Lin, C-F. ,
Lee, W-H. ,
Kuo, C-H. &
Lee, K-Y. ,
7月 2018 ,
於: Journal of Thoracic Oncology. 13 ,
7 ,
p. 958-967 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Myeloid-Derived Suppressor Cells
100%
Bevacizumab
83%
Adenocarcinoma of Lung
80%
Protein-Tyrosine Kinases
68%
Progression-Free Survival
24%
Chen, K. C. ,
Chen, C. R. ,
Chen, C. Y. ,
Tzou, K. Y. ,
Peng, C. C. &
Peng, R. Y. ,
5月 1 2020 ,
於: International journal of molecular sciences. 21 ,
9 , 3400.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Reactive oxygen species
100%
Bicalutamide
95%
Mesangial Cells
89%
bicalutamide
84%
Hypoxia-Inducible Factor 1
71%
Chen, K. C. ,
Chen, C. R. ,
Chen, C. Y. ,
Peng, C. C. &
Peng, R. Y. ,
1月 1 2022 ,
於: Journal of Clinical Medicine. 11 ,
1 , 135.
研究成果: 雜誌貢獻 › 文章 › 同行評審
bicalutamide
100%
Mitochondrial Dynamics
86%
Kidney
35%
Autosomal Dominant Optic Atrophy
30%
NADPH Oxidase 4
30%
Peng, C. C. ,
Chen, C. R. ,
Chen, C. Y. ,
Chen, K. C. &
Peng, R. Y. ,
4月 1 2022 ,
於: Chemico-Biological Interactions. 356 , 109858.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Bicalutamide
100%
bicalutamide
88%
Glycolysis
62%
Kidney
31%
Wounds and Injuries
28%
Liao, Y. T. ,
Liu, C. H. ,
Chin, Y. ,
Chen, S. Y. ,
Liu, S. H. ,
Hsu, Y. C. &
Wu, K. C. W. ,
2019 ,
於: Journal of Materials Chemistry B. 7 ,
28 ,
p. 4451-4460 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Gold Nanorods
100%
Epithelial Cells
78%
Biocompatible Material
44%
Nanorod
42%
Cells
14%
Zheng, C. ,
Liao, M. T. ,
Lin, M. Y. ,
Lo, L. ,
Wu, C-C. ,
Hsu, Y-H. ,
Lin, Y-F. &
Lu, K-C. ,
1月 20 2013 ,
於: Open Journal of Nephrology. p. 51-60 10 p. , 3.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chen, J. H. ,
Lee, C. H. ,
Lee, M. R. ,
Huang, P-Y. ,
Yen, T. H. ,
Lee, M. C. ,
Tsai, C. W. ,
Wang, J. Y. &
Lee, J. A. ,
2022 , (接受/付印)
於: Journal of Clinical Pharmacology. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Diphosphonates
100%
Osteoporosis
80%
Tuberculosis
74%
Cohort Studies
62%
Bone Fractures
28%
Lee, C-M. ,
Su, Y-H. ,
Huynh, T. T. ,
Lee, W. H. ,
Chiou, J. F. ,
Lin, Y-K. ,
Hsiao, M. ,
Wu, C. H. ,
Lin, Y. F. ,
Wu, A. T. H. &
Yeh, C-T. ,
2013 ,
於: Evidence-based Complementary and Alternative Medicine. 2013 , 258425.
研究成果: 雜誌貢獻 › 文章 › 同行評審
pterostilbene
100%
Blueberry Plants
91%
Neoplastic Stem Cells
63%
Hepatocellular Carcinoma
48%
Stem Cells
43%
Bone Morphogenetic Protein 1
100%
Ankylosing Spondylitis
67%
Bone Morphogenetic Proteins
33%
Bone Morphogenetic Protein 2
23%
Bone Morphogenetic Protein 7
12%
Wu, Y. H. ,
Wu, W. S. ,
Lin, L. C. ,
Liu, C. S. ,
Ho, S. Y. ,
Wang, B. J. ,
Huang, B. M. ,
Yeh, Y. L. ,
Chiu, H. W. ,
Yang, W. L. &
Wang, Y. J. ,
4月 27 2018 ,
於: Journal of Experimental and Clinical Cancer Research. 37 ,
1 ,
p. 91 91.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
100%
Bortezomib
83%
Radiation Tolerance
79%
Oncogene Proteins
76%
Mouth Neoplasms
74%
Wu, Y-N. ,
Liao, C-H. ,
Wu, C-C. &
Chiang, H-S. ,
2015 ,
於: Urological Science. 26 ,
4 ,
p. 290 1 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chen, K. C. ,
Hsieh, C. L. ,
Peng, C. C. ,
Hsieh-Li, H. M. ,
Chiang, H-S. ,
Huang, K. D. &
Peng, R. Y. ,
2007 ,
於: Nutrition and Cancer. 58 ,
1 ,
p. 93-106 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Psidium
100%
Prostatic Neoplasms
48%
Brain
30%
In Vitro Techniques
27%
Matrix Metalloproteinases
16%
Wen, Y-C. ,
Lee, W. J. ,
Tan, P. ,
Yang, S. F. ,
Hsiao, M. ,
Lee, L. M. &
Chien, M. H. ,
2015 ,
於: Oncotarget. 6 ,
25 ,
p. 21120-21136 17 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
osthol
100%
Snails
73%
Epithelial-Mesenchymal Transition
62%
Cadherins
60%
Prostatic Neoplasms
47%
Tsai, Y. T. ,
Sung, L. C. ,
Haw, W. R. ,
Chen, C. C. ,
Huang, S. F. ,
Liu, J. C. ,
Cheng, T. H. ,
Chen, P. Y. ,
Loh, S. H. &
Tsai, C. S. ,
2月 5 2018 ,
於: European Journal of Pharmacology. 820 ,
p. 106-112 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
cafestol
100%
urotensin II
83%
Diterpenes
71%
Coffee
62%
Human Umbilical Vein Endothelial Cells
56%
Hao, W. R. ,
Sung, L. C. ,
Chen, C. C. ,
Hong, H. J. ,
Liu, J. C. &
Chen, J. J. ,
1月 1 2019 ,
於: American Journal of Chinese Medicine. 47 ,
2 ,
p. 337-350 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
cafestol
100%
urotensin II
83%
Cardiac Myocytes
49%
Hypertrophy
48%
Coffee
17%
Hao, W. R. ,
Sung, L. C. ,
Chen, C. C. ,
Chen, P. Y. ,
Cheng, T. H. ,
Chao, H. H. ,
Liu, J. C. &
Chen, J. J. ,
1月 1 2018 ,
於: Oxidative Medicine and Cellular Longevity. 2018 ,
1 p. , 7861518.
研究成果: 雜誌貢獻 › 文章 › 同行評審
cafestol
100%
Cafestol
96%
Chemoattractant
77%
Chemokine CCL2
59%
Intercellular Adhesion Molecule-1
55%
Hou, C. P. ,
Tsui, K. H. ,
Chang, K. S. ,
Sung, H. C. ,
Hsu, S. Y. ,
Lin, Y. H. ,
Yang, P. S. ,
Chen, C. L. ,
Feng, T. H. &
Juang, H. H. ,
2022 , (接受/付印)
於: Biomedical Journal. 研究成果: 雜誌貢獻 › 文章 › 同行評審
caffeic acid phenethyl ester
100%
Growth Differentiation Factor 15
97%
Urinary Bladder
50%
Carcinoma
42%
SERPIN-B5
34%
Kao, C. C. ,
Liu, J. S. ,
Chang, Y. K. ,
Lin, M. H. ,
Lin, Y. C. ,
Chen, H. H. ,
Chang, W. C. ,
Hsu, C. C. &
Wu, M. S. ,
1月 1 2018 ,
於: PeerJ. 2018 ,
11 , e5864.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Mammalian Target of Rapamycin Inhibitor
100%
kidney transplant
85%
Kidney Transplantation
54%
Antineoplastic Agent
51%
neoplasms
44%
Huan, S. K. H. ,
Lee, H. H. ,
Liu, D. Z. ,
Wu, C. C. &
Wang, C. C. ,
6月 1 2006 ,
於: Toxicology. 223 ,
1-2 ,
p. 136-143 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cantharidin
100%
Cyclooxygenase 2
60%
Urinary Bladder
46%
Carcinoma
38%
Cell Line
34%
Shang, H. S. ,
Liu, J. Y. ,
Lu, H. F. ,
Chiang, H. S. ,
Lin, C. H. ,
Chen, A. ,
Lin, Y. F. &
Chung, J. G. ,
8月 2017 ,
於: Environmental Toxicology. 32 ,
8 ,
p. 2041-2052 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Casticin
100%
casticin
97%
gene expression
60%
Apoptotic
59%
Cell Death
54%
Chiu, H. W. ,
Xia, T. ,
Lee, Y. H. ,
Chen, C. W. ,
Tsai, J. C. &
Wang, Y. J. ,
1月 14 2015 ,
於: Nanoscale. 7 ,
2 ,
p. 736-746 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nanospheres
100%
Cell death
89%
Polystyrenes
68%
Cell Death
64%
Nanosphere
58%
Hou, C. C. ,
Hung, S. L. ,
Kao, S. H. ,
Chen, T. H. &
Lee, H. M. ,
2005 ,
於: Annals of the New York Academy of Sciences. 1042 ,
p. 235-245 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Celecoxib
100%
Heme Oxygenase (Decyclizing)
95%
Mesangial Cells
84%
Heme Oxygenase-1
82%
Heme
65%
Chiang, H-S. ,
Lu, J. F. ,
Liu, C. H. ,
Wu, Y. N. &
Wu, C. C. ,
9月 2009 ,
於: Clinical Genetics. 76 ,
3 ,
p. 282-286 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Congenital bilateral aplasia of vas deferens
100%
Cystic Fibrosis
59%
Incidence
29%
Population
23%
Mutation
21%
Chiang, H-S. ,
Wu, C. C. ,
Wu, Y. N. ,
Lu, J. F. ,
Lin, G. H. &
Hwang, J-L. ,
9月 2008 ,
於: Journal of the Formosan Medical Association = Taiwan yi zhi. 107 ,
9 ,
p. 736-740 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Congenital bilateral aplasia of vas deferens
100%
Cystic Fibrosis Transmembrane Conductance Regulator
76%
Intracytoplasmic Sperm Injections
72%
Twins
64%
Fathers
59%
Wu, M-S. ,
Hsieh, M-H. ,
Hsu, Y-H. ,
Pan, S. ,
Chen, C. N. ,
Chan, P. &
Kao, P-F. ,
9月 1991 ,
於: New Taipei Journal of Medicine. 3 ,
3 ,
p. 182-186 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Wu, C. Z. ,
Chang, L. C. ,
Lin, Y. F. ,
Hung, Y. J. ,
Pei, D. &
Chen, J. S. ,
2015 ,
於: Disease Markers. 2015 , 548101.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chaperonin Containing TCP-1
100%
Chaperonins
86%
Protein Subunits
66%
Diabetic Nephropathies
62%
Biological Marker
52%
TAIPAI Study Group ,
12月 2021 ,
於: Biomedicines. 9 ,
12 , 1816.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Glucocorticoid-Remediable Aldosteronism
100%
Aldosterone
79%
Hyperaldosteronism
71%
Plasma
34%
Hypertension
29%